Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV001526615 | SCV001737045 | pathogenic | Intellectual disability | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV003382623 | SCV004088482 | pathogenic | Inborn genetic diseases | 2023-09-12 | criteria provided, single submitter | clinical testing | The c.1806C>G (p.Y602*) alteration, located in exon 16 (coding exon 16) of the DDX3X gene, consists of a C to G substitution at nucleotide position 1806. This changes the amino acid from a tyrosine (Y) to a stop codon at amino acid position 602. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). Based on the available evidence, this alteration is classified as pathogenic. |